WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 29'1801 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 32'1031 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 46'927  46'755  46'514  46'182  45'754  40'283  38'883  37'493 
Births 488  493  496  496  494  397  395  575 
Surviving infants 486  491  494  495  492  395  392  567 
Pop. less than 5 years 2'530  2'545  2'543  2'521  2'490  1'865  2'055  3'134 
Pop. less than 15 years 7'205  7'119  7'015  6'894  6'782  5'953  7'729  9'739 
Female 15-49 years 11'063  11'185  11'285  11'354  11'362  10'435  9'672  8'849 

Number of reported case

(Click for retrospective incidence data for Spain)
Diphtheria
Japanese encephalitis
Measles 131  1'204  3'802  302  41  152  21'650  145'322 
Mumps 13'951  9'539  4'416  2'516  2'036  9'391 
Pertussis 2'342  3'439  3'088  739  393  921  10'075 
Polio* 17 
Rubella 64  30  20  345 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 13  12  27  54  500 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Spain)
Vaccine year result method % card seen                                                
BCG         
DTP1         
DTP3          96  97  97  97  96  95  86 
HepB_BD         
HepB3          95  96  97  97  96  77 
Hib3          96  97  97  97  96  92 
JapEnc         
MCV          95  97  97  95  98  94  99 
MCV2          91  90  91  92  90 
PCV1         
PCV3         
Pol3          96  97  97  97  96  95  94 
Rota1         
Rota_last         
Rubella1          95  97  95  98 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Spain)
DTP1 98  99  99  99  98  98  95 
DTP3 96  97  97  97  96  95  86 
HepB3 95  96  97  97  96  77 
HepB_BD
Hib3 96  97  97  97  96  92 
MCV 95  97  97  95  98  94  99 
MCV2 91  90  91  92  90 
PnC3
Pol3 96  97  97  97  96  95  94 
Rota_last

Number of districts in the country 19  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 89
From 80 to 89% 11
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 2, 6 months; Yes
DTaPHibIPV 4, 18 months; Yes
HPV 11-14 years (x3); Yes
HepA Yes risk groups
HepB birth; Yes and adults at risk
Influenza >64 years; Yes and risk groups
MMR 12 months; 3-4 years; Yes
MenACWY Yes Risk groups
MenC_conj 2,4, 12-18 months; Yes
Pneumo_conj Yes high risk groups
Pneumo_ps > 65 years; and risk groups
Td 14 years; Yes
Tdap 6 years; Yes
Varicella 10-14 years (x2); Yes and rtisk groups

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR NA  NA  NA  NA  NA  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 19  19  19  19  19  19  19 
Nº districts with DTP3 coverage >=80% number 19  19  17  18  15  15 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  89  95  79  79 
Nº districts with measles (MCV1) coverage >=95% number 15  15  15  16  15  15   
% of districts with MCV1 coverage >=95% From 0 to 100% 79  79  79  84  79  79   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%       100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.